The global swine artificial insemination market size was estimated at around USD 1.94 billion in 2022 and it is projected to hit around USD 3.71 billion by 2032, growing at a CAGR of 6.69% from 2023 to 2032. The swine artificial insemination market in the United States was accounted for USD 0.24 billion in 2022.
Key Pointers
Report Scope of the Swine Artificial Insemination Market
Report Coverage | Details |
Revenue Share of Asia Pacific in 2022 | 30.04% |
CAGR of Latin America from 2023 to 2032 | 7.03% |
Revenue Forecast by 2032 | USD 3.71 billion |
Growth Rate from 2023 to 2032 | CAGR of 6.69% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Companies Covered | Genus Plc; IMV Technologies; Shipley Swine Genetics; Agtech, Inc.; Neogen Corporation.; GenePro, Inc. ; MINITÜB GMBH; Swine Genetics International; Hypor BV; Semen Cardona S.L. |
Increasing consumption of pork meat, adoption of artificial insemination in swine, demand for sustainable food production, and initiatives by key market players are some of the leading factors contributing to the market growth. As per OECD estimates, global consumption of pork meat is projected to increase from 112.58 megatons in 2022 to 127.27 megatons in 2029. Amongst the several countries, China is a major producer as well as consumer of pork meat and is expected to remain dominant over the forecast period.
The market was significantly impacted by the African swine fever, the COVID-19 pandemic, as well as the macroeconomic challenges of 2022. A major impact of the African Swine Fever was observed in 2018-19 wherein there was a notable decline in sow herds in key markets such as China. Customers in the value chain also faced issues such as high grain, fuel, and fertilizer prices; the continued adverse impact of COVID-19 on operations, supply chain hurdles, and inflationary pressures on input costs.
Although certain challenges persist during 2023, the market is expected to grow steadily in key countries. The outbreak of diseases like African Swine fever, and other challenges have pushed market leaders to innovate swine production. These challenges coupled with the growing reality of market consolidation continue to push for higher productivity and output. For example, Genus Plc, a leading market player, expanded its pig production post the shortfall in pork, with technified pig production, which was also supported by the legislative drive to professionalize the sector.
Market players have begun to leverage the growing opportunities in the market. For example, at the end of 2022, Hendrix Genetics established a business unit in China. The company started by establishing nuclear and pedigree farms for popular species in the country, with an initial focus on swine and poultry. Furthermore, companies such as Semen Cardona S.L. are exploring opportunities in emerging markets such as the Philippines, Mexico, Colombia, etc. The company distributed over 0.7 million doses of semen in 2022, in Mexico. Similar initiatives by key players in the market are estimated to drive market growth in the coming years.
The demand in the swine artificial insemination market has been increasing over the years due to its numerous benefits such as the ability to improve genetics, reduce disease transmission, and increase productivity. Moreover, artificial insemination can be used to improve the overall productivity and profitability of pig farming. By using high-quality semen from genetically superior boars, pig farmers can produce piglets that have better growth rates, increased meat yield, and improved feed conversion ratios. This ultimately leads to higher profits for pig farmers. Growing awareness of the benefits of artificially inseminating pigs is thus expected to propel the market growth during the forecast period.
Solutions Insights
The services segment dominated the market with a share of over 40.03% in 2022. On the other hand, the semen segment is projected to grow at the highest rate of over 7% in the near future. Factors contributing to the growth include advancements in breeding technology and rising demand for sustainable swine production. The demand for services such as reproduction consulting, semen collection, breeding programs, artificial insemination, etc. is on the rise thus attributing to the high share of the segment.
The swine sector has increasingly adopted artificial insemination as a way to improve the genetic potential, productivity, and profitability of pig farming. With the growing demand for pork worldwide, artificial insemination is expected to play an important role in meeting this demand and ensuring the sustainability of the swine industry.Shipley Swine Genetics, for example, offers swine genetic programs and swine seminal fluid to a wide range of customers.Semen Cardona S.L. is another key player that specializes in swine genetics and has distributed over 5 million semen doses in 2022.
Distribution channel Insights
In terms of distribution channels, the private segment held the largest market share in 2022. It is also expected to grow at the fastest rate of about 7.02% in the coming years. This is due to the increasing adoption of online channels as well as direct sales initiatives and distribution partnerships initiated by market players. Many e-commerce companies such as Alibaba.com offer pig artificial insemination products and supplies to customers. Market players such as Swine Genetics International provide direct sales options to customers
Vetline Services is a private company based in Uganda that provides services and products to the pig sector. Its services include artificial insemination, boar semen analysis, pregnancy scanning, training, and consulting among others. Similar offerings directly provided to customers are contributing to the high share of the private channel segment across the globe. The public segment is also expected to grow notably in the coming years with supportive initiatives from governments and other public sector stakeholders.
Regional Insights
Asia Pacific dominated the market by region with a share of about 30.04% in 2022. This is due to the high population of pigs, the rising adoption of artificial insemination, and the need to meet global animal protein demand more sustainably. As per FAO estimates, the global pig population in 2022 was about 975 million. Of this, an estimated 559 million pigs were in the Asia Pacific alone. China, for instance, is a major pork producer which is expected to contribute to the regional growth.
Latin America region is projected to grow at the fastest CAGR of over 7.03% in the coming years. In 2022, Latin America was estimated to have the second-largest pig population at about 97 million. Moreover, as per Genesus Inc. the region accounts for some of the largest producers. This includes the BRF S.A. a Brazilian company with an estimated 0.39 million sows and Aurora Alimentos in Brazil with an estimated 0.26 million sows in 2021.
Swine Artificial Insemination Market Segmentations:
By Solutions
By Distribution Channel
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Swine Artificial Insemination Market
5.1. COVID-19 Landscape: Swine Artificial Insemination Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Swine Artificial Insemination Market, By Solutions
8.1. Swine Artificial Insemination Market, by Solutions, 2023-2032
8.1.1. Equipment & Consumables
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Semen
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Swine Artificial Insemination Market, By Distribution
9.1. Swine Artificial Insemination Market, by Distribution, 2023-2032
9.1.1. Private
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Public
9.1.2.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Swine Artificial Insemination Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.1.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.1.3.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.1.4.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.2.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.2.3.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.2.4.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.2.5.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.2.6.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.3.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.3.3.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.3.4.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.3.5.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.3.6.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.4.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.4.3.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.4.4.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.4.5.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.4.6.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.5.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.5.3.2. Market Revenue and Forecast, by Distribution (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Solutions (2020-2032)
10.5.4.2. Market Revenue and Forecast, by Distribution (2020-2032)
Chapter 11. Company Profiles
11.1. Genus Plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. IMV Technologies
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Shipley Swine Genetics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Agtech, Inc.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Neogen Corporation.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. GenePro, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. MINITÜB GMBH
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Swine Genetics International
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Hypor BV
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Semen Cardona S.L.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms